21796626|play|C0032214|start=67|end=71|ACTI
21796626|key|C1554080^C1706198|start=72|end=75|CONC
21796626|roles|C0035820|start=76|end=81|ACTI
21796626|mitotic|C1513354|start=100|end=107|CONC
21796626|phase|C0205390|start=108|end=113|CONC
21796626|eukaryotic cell|C0015161|start=121|end=136|ANAT
21796626|cycle|C1511572|start=137|end=142|CONC
21796626|numerous|C0439064|start=173|end=181|CONC
21796626|tumors|C0027651|start=182|end=188|DISO
21796626|including|C0332257|start=189|end=198|CONC
21796626|b-cell|C0004561|start=199|end=205|ANAT
21796626|lymphomas|C0024299|start=220|end=229|DISO
21796626|oncology|C1552534^C1555459^C0278627|start=248|end=256|OCCU^OBJC^ORGA^CONC
21796626|pan|C1514599^C0030266^C2244316^C0031036|start=276|end=279|DISO^GEOG^ORGA^ANAT
21796626|inhibitor|C1999216|start=287|end=296|CONC
21796626|inhibited|C0311403|start=297|end=306|CONC
21796626|growth|C2911660^C0220844^C0018270^C1621966|start=307|end=313|PHYS^ACTI
21796626|survival|C0038952^C0220921|start=318|end=326|ACTI^CONC
21796626|multiple|C0439064|start=330|end=338|CONC
21796626|solid tumors|C0280100|start=339|end=351|DISO
21796626|in vitro|C1533691^C2827718^C0021135|start=352|end=360|CONC
21796626|in vivo|C1515655|start=365|end=372|CONC
21796626|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=382|end=387|PROC^OBJC^CONC
21796626|activity|C0026606^C0441655^C0205177|start=428|end=436|ACTI^CONC
21796626|variety|C2346866^C1883525|start=459|end=466|CONC
21796626|aggressive|C1548760^C0001807^C1550594^C0580822^C1547300|start=470|end=480|DISO^CONC
21796626|non-hodgkin lymphoma|C0024305^C3539720|start=484|end=504|DISO^CONC
21796626|nhl|C1539711^C0079745^C0024305|start=508|end=511|DISO^GENE
21796626|cell lines|C0007600|start=512|end=522|ANAT
21796626|cells|C3282337^C0007634|start=524|end=529|ANAT
21796626|treated with|C0332293^C1522326|start=530|end=542|PROC^CONC
21796626|endoreduplication|C0333688|start=560|end=577|DISO
21796626|confirming|C0521093^C0750484|start=578|end=588|CONC
21796626|mechanism of action|C1524059^C0031327|start=593|end=612|PHYS^CONC
21796626|inhibitor|C1999216|start=628|end=637|CONC
21796626|treatment|C1705169^C0039798^C1533734^C3161471^C1522326^C3538994^C0087111|start=645|end=654|PROC^CONC
21796626|nhl|C1539711^C0079745^C0024305|start=660|end=663|DISO^GENE
21796626|cell lines|C0007600|start=664|end=674|ANAT
21796626|induced|C0205263|start=687|end=694|CONC
21796626|apoptosis|C0162638|start=695|end=704|PHYS
21796626|dose|C0869039^C0178602|start=710|end=714|CONC
21796626|time|C0040223^C1548318^C1547403^C3541383|start=719|end=723|CONC
21796626|dependent|C3244310^C1701901^C0851827|start=724|end=733|CONC
21796626|inhibited|C0311403|start=745|end=754|CONC
21796626|cell proliferation|C0596290|start=755|end=773|PHYS
21796626|known|C0205309|start=809|end=814|CONC
21796626|inhibition|C0021467^C3463820^C0021469|start=820|end=830|PHYS^ACTI
21796626|effects|C1280500|start=880|end=887|CONC
21796626|microtubule|C0026046|start=891|end=902|ANAT
21796626|targeting|C0599894^C1521840|start=903|end=912|PHYS^CONC
21796626|induce|C0205263|start=959|end=965|CONC
21796626|apoptosis|C0162638|start=988|end=997|PHYS
21796626|evaluated|C0220825|start=1002|end=1011|PROC
21796626|combination|C1947911^C0205195|start=1030|end=1041|OBJC^CONC
21796626|efficient|C0442799|start=1065|end=1074|CONC
21796626|inducing|C0205263|start=1078|end=1086|CONC
21796626|apoptosis|C0162638|start=1087|end=1096|PHYS
21796626|low|C1611820^C1619811^C0205251^C1550472^C2700150|start=1137|end=1140|CONC
21796626|doses|C0178602|start=1141|end=1146|CONC
21796626|apoptosis|C0162638|start=1154|end=1163|PHYS
21796626|doubled|C0205173|start=1168|end=1175|CONC
21796626|combination|C1947911^C0205195|start=1183|end=1194|OBJC^CONC
21796626|compared|C1707455|start=1201|end=1209|ACTI
21796626|xenograft model|C1520166|start=1254|end=1269|DISO
21796626|mantle cell lymphoma|C0334634|start=1273|end=1293|DISO
21796626|tumor|C0027651^C1578706|start=1378|end=1383|DISO^CONC
21796626|activity|C0026606^C0441655^C0205177|start=1384|end=1392|ACTI^CONC
21796626|plus|C0332287|start=1450|end=1454|CONC
21796626|statistically significant|C0237881|start=1491|end=1516|CONC
21796626|tumor growth|C0598934|start=1517|end=1529|DISO
21796626|inhibition|C0021467^C3463820^C0021469|start=1530|end=1540|PHYS^ACTI
21796626|enhanced|C2349975|start=1545|end=1553|ACTI
21796626|survival|C0038952^C0220921|start=1554|end=1562|ACTI^CONC
21796626|suggest|C1705535|start=1586|end=1593|CONC
21796626|plus|C0332287|start=1606|end=1610|CONC
21796626|may|C3812381|start=1621|end=1624|CONC
21796626|represent|C1882932|start=1625|end=1634|ACTI
21796626|novel|C0205314^C0679622|start=1637|end=1642|CONC
21796626|therapeutic|C0039796^C1547427^C0302350|start=1643|end=1654|PROC^CONC
21796626|strategy|C0679199|start=1655|end=1663|PHYS
21796626|b-cell|C0004561|start=1667|end=1673|ANAT
21796626|nhl|C1539711^C0079745^C0024305|start=1674|end=1677|DISO^GENE
21796626|early|C1279919|start=1690|end=1695|CONC
21796626|phase|C0205390|start=1696|end=1701|CONC
21796626|clinical trial|C1096775^C1552009^C0008976^C3714778|start=1702|end=1716|PROC^CONC
21796626|evaluation|C1550157^C1261322^C0220825|start=1717|end=1727|PROC^CONC
